3:14:39 PM PDT - Sunday, October 25th, 2020

Kodak’s Moment of Investor Insanity Has Passed, But Its Future Is Unclear  

By Editor - Sun Oct 18, 5:44 am

Kodak (NYSE:KODK) released a report from its lawyers on Sept. 15 that provides for very interesting reading. Anybody considering investing in Kodak stock should carefully cull through it. It will help you assess Kodak’s move to diversify into the pharmaceutical manufacturing business. Source: Katherine Welles / Shutterstock.com The report, which is easy to read and very detailed, shows the background to the company’s move to try and get a $765 million starter loan from the U.S. government. In the end, the loan was put on hold, but the whole story about how the loan came about is very interesting. The loan, from the International Development Finance Corporation (DFC), was a way for Kodak to make novel coronavirus vaccine-related key starter materials (KSM)

Excerpt from:

Kodak’s Moment of Investor Insanity Has Passed, But Its Future Is Unclear

Leave a Reply

You must sign in to post a comment.